JAMES OSWALT: Open Payments
NPI 1205550829 · GAHANNA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 28 payments from 10 companies in 2025. Trend: 2023 $1,731 · 2024 $1,190 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $382 |
| IMMUNITYBIO, INC. | 3 | $227 |
| PFIZER INC. | 1 | $121 |
| Endo USA, Inc. | 1 | $98 |
| Antares Pharma, Inc. | 3 | $61 |
| Verity Pharmaceuticals Inc. | 2 | $57 |
| UROGEN PHARMA, INC. | 2 | $45 |
| Medtronic, Inc. | 2 | $27 |
| Olympus America Inc. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
Products named: GEMTESA, ANKTIVA, XTANDI, XIAFLEX, XYOSTED, Trelstar, JELMYTO, INTERSTIM.
Industry payments across OH — which companies pay providers there.
